Lataa...

A trial of sublingual buprenorphine in cancer pain

1 Buprenorphine is a new antagonist analgesic which was offered sublingually to 141 patients with moderate cancer pain as an alternative to their current analgesic. These patients were not on regular strong morphine-like analgesics. 2 Forty-seven patients used the drug on demand in unit doses rangin...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijä: Robbie, D. S.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 1979
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC1429302/
https://ncbi.nlm.nih.gov/pubmed/380617
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!